Use of a Modified Hemi-body Irradiation Technique for Metastatic Carcinoma of the Prostate: Report of a 10-year Experience

Clinical Oncology

Volumn 20, Issue 8, 2008, Pages 591-598

  Bashir, F A ^a   Parry, J M ^a   Windsor, P M ^a  

^a Tayside Cancer Centre   (United Kingdom)

Author keywords

Bone metastases; hemi body irradiation; pain palliation; prostate cancer; radiotherapy

Indexed keywords

ANALGESIC AGENT; ANTIANDROGEN; ANTIEMETIC AGENT; GONADORELIN AGONIST; HYDROCORTISONE; METOCLOPRAMIDE; PAMIDRONIC ACID; STRONTIUM 89; TECHNETIUM;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DIARRHEA; FATIGUE; FOLLOW UP; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA AND VOMITING; ORCHIECTOMY; PAIN ASSESSMENT; PANCYTOPENIA; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION FIELD; RETROSPECTIVE STUDY; SPINAL CORD COMPRESSION; SURVIVAL RATE; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; BONE NEOPLASMS; HEMIBODY IRRADIATION; HUMANS; MALE; MIDDLE AGED; PAIN; PALLIATIVE CARE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 51249123746     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.05.005     Document Type: Article

References (18)

1. Barton R., and Kirkbride P. Special techniques in palliative radiation oncology. J Palliat Med 3 1 (2000) 75-83
2. Fitzpatrick P.J., and Rider W.D. Half body radiotherapy. Int J Radiat Oncol Biol Phys 1 (1976) 197-207
3. Poulter C., Cosmatos D., Rubin P., et al. A report of RTOG 82-06: a phase III study of whether the addition of single dose hemibody irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases. Int J Radiat Oncol Biol Phys 23 (1992) 207-214
4. Scarantino C.W., Caplan R., Rotman M., et al. A phase I/II study to evaluate the effect of fractionated hemi-body irradiation in the treatment of osseous metastases - RTOG 88-22. Int J Radiat Oncol Biol Phys 36 1 (1996) 37-48
5. Windsor P.M. Predictors of response to strontium-89 (Metastron) in skeletal metastases from prostate cancer: report of a single centre's 10-year experience. Clin Oncol 12 (2001) 219-227
6. Soloway M.S., Hardeman S.W., Hickey D., et al. Stratification of patients with metastatic prostate cancer based on the extent of disease on initial bone scan. Cancer 61 (1988) 195-202
7. Chow E., Wu J.S.Y., Hoskin P., Coia L.R., Bentzen S.M., Blitzer P.H., and on behalf of the International Bone Metastases Consensus Working Party. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 64 3 (2002) 275-280
8. Quilty P.M., Kirk D., Bolger J.J., et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 56 (1994) 3133-3140
9. Biswal B.M. Assessment of the usefulness of hemibody irradiation in painful bone metastasis. J Indian Med Assoc 102 3 (2004) 133-134 136-137
10. Hoskin P.J., Ford H.T., and Harmer C.L. Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patients. Clin Oncol (R Coll Radiol) 1 2 (1989) 67-69
11. Dearnaley D.P., Bayly R.J., A'Hern R.P., Gadd J., Zivanovic M.M., and Lewington V.J. Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?. Clin Oncol (R Coll Radiol) 4 2 (1992) 101-107
12. McQuay H.J., Collins S.L., Carroll D., et al. Radiotherapy for the palliation of painful bone metastases. The Cochrane Library Issue 4 (2001)
13. Kirkbride P. Radiation-induced emesis. In: Hesketh P.J. (Ed). Management of nausea and vomiting in cancer and cancer treatment (2005), Jones & Bartlett
14. Sykes A.J., Kiltie A.E., and Stewart A.L. Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy. Support Care Cancer 5 6 (1997) 500-503
15. Logue J.P., Magee B., Hunter R.D., and Murdoch R.D. The antiemetic effect of granisetron in lower hemibody radiotherapy. Clin Oncol (R Coll Radiol) 3 5 (1991) 247-249
16. Farley E., Yang M.D., Florin Vaida M.S., et al. Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy. Int J Radiat Oncol Biol Phys 33 3 (1995) 607-617
17. Tannock I.F., de Wit R., Berry W.R., et al. Docetaxol plus prednisolone or mitoxantrone plus prednisolone for advanced prostate cancer. N Engl J Med 351 (2004) 1502-1512
18. Saad F., Gleason D.M., Murray R., et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 96 (2004) 879-882